Working Towards Cervical Cancer-Free Futures Globally
With support from the Gates Foundation, JSI leads the HPV Vaccine Acceleration Program Partners Initiative (HAPPI) Consortium. Through technical assistance and implementation research, the consortium has supported over 20 countries with HPV vaccine introduction, product switches, and program improvements, contributing to protection for over 34.1 million girls from cervical cancer. As one of Gavi’s first technical assistance providers for HPV vaccine rollout, we have supported the successful submissions of over 46% of all applications to Gavi for HPV vaccine TA since 2023, 25% of the HPV vaccine new introductions, and 45% of the multi-age cohort campaigns, helping Gavi reach its goal of 86 million girls vaccinated ahead of schedule.
Learn more about the HAPPI Consortium.